Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Botulinum neurotoxin injection manual / / editors, Katharine E. Alter, Nicole A. Wilson
| Botulinum neurotoxin injection manual / / editors, Katharine E. Alter, Nicole A. Wilson |
| Pubbl/distr/stampa | New York, New York : , : Demos Medical, , 2015 |
| Descrizione fisica | 1 online resource (369 p.) |
| Disciplina | 615.7/78 |
| Soggetto topico |
Botulinum toxin - Therapeutic use
Injections Nervous system - Diseases - Treatment |
| Soggetto genere / forma | Electronic books. |
| ISBN | 1-61705-209-4 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Cover; Title; Copyright; Contents; Contributors; Preface; Share Botulinum Neurotoxin Injection Manual; Section One: Botulinum Neurotoxin: Basic Science and Reconstitution; Chapter 1: Pharmacology of Botulinum Neurotoxins; Normal Neurotransmitter Release; BoNTs Synthesis and Structure; BoNT Binding/Blocking; BoNT Potency and Dosing; Clinical Implications of BoNT Pharmacology; Antigenicity, Antibody Formation, and Nonresponsiveness to BoNT; Safety; Central Effects of BoNTs; Summary; Chapter 2: Comparison of Botulinum Neurotoxin Products; BoNT Approvals
BoNT Products: Antigenicity, Dilution, and DiffusionBoNT Products: Potency and Dose; Converting Units/Dose Among BoNT Products; Summary; Chapter 3: Neurotoxin Storage, Reconstitution, Handling, and Dilution; Serotype B BoNT; Serotype A BoNTs; OnabotulinumtoxinA (Botox®) Reconstitution and Handling; AbobotulinumtoxinA (Dysport®) Reconstitution and Handling; IncobotulinumtoxinA (Xeomin®) Reconstitution and Handling; RimabotulinumtoxinB (Myobloc® in the United States, NeuroBloc® Outside the United States) Reconstitution and Handling; Injection Supplies; Needle Selection Chapter 4: Guidance Techniques for Botulinum Neurotoxin InjectionsAnatomic Reference Guides, Surface Anatomy, and Palpation Guidance; EMG Guidance; Electrical Stimulation Guidance; B-Mode Ultrasound; Combinations of Techniques; Other Guidance Techniques for BoNT Injections; Summary; Chapter 5: Phenol Nerve Blocks; Why Consider Phenol Neurolysis?; Phenol Mechanism of Action; Muscle Hypertonia; Pattern of Involvement; Injection Technique and Dosing; Musculocutaneous Nerve; Obturator Nerve; Tibial Motor Nerves; Summary; Section Two: Clinical Applications of Botulinum Neurotoxins Part I: Botulinum Neurotoxins for the Treatment of Muscle Overactivity Associated with Focal Dystonia Syndromes and Upper Motor Neuron SyndromesCraniofacial Dystonia; Chapter 6: Benign Essential Blepharospasm; Chapter 7: Botulinum Neurotoxin Therapy for Hemifacial Spasm; Chapter 8: Botulinum Neurotoxin Injections for Oromandibular Dystonias; Illustrations for Craniofacial Dystonia; Cervical Dystonia; Chapter 9: Botulinum Neurotoxin Injections for Cervical Dystonia; Illustrations for Cervical Dystonia; Upper Limb, Lower Limb, and Trunk Dystonia Chapter 10: Botulinum Neurotoxin for the Treatment of Idiopathic Primary Focal Limb DystoniaChapter 11: Botulinum Neurotoxin for Treatment of Muscle Overactivity Associated with Upper Motor Neuron Syndromes; Chapter 12: Botulinum Neurotoxin for the Treatment of Trunk Dystonia/Camptocormia; Chapter 13: Botulinum Neurotoxin Injections for the Treatment of Tremor; Illustrations for Upper Limb, Lower Limb, and Trunk Dystonia; Part II: Botulinum Neurotoxins for Neurosecretory Disorders; Chapter 14: Botulinum Neurotoxin Therapy for Problematic Sialorrhea; Condition Chapter 15: Botulinum Neurotoxin Therapy for Hyperhidrosis |
| Record Nr. | UNINA-9910463779103321 |
| New York, New York : , : Demos Medical, , 2015 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Botulinum neurotoxin injection manual / / editors, Katharine E. Alter, Nicole A. Wilson
| Botulinum neurotoxin injection manual / / editors, Katharine E. Alter, Nicole A. Wilson |
| Pubbl/distr/stampa | New York, New York : , : Demos Medical, , 2015 |
| Descrizione fisica | 1 online resource (369 p.) |
| Disciplina | 615.7/78 |
| Soggetto topico |
Botulinum toxin - Therapeutic use
Injections Nervous system - Diseases - Treatment |
| ISBN | 1-61705-209-4 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Cover; Title; Copyright; Contents; Contributors; Preface; Share Botulinum Neurotoxin Injection Manual; Section One: Botulinum Neurotoxin: Basic Science and Reconstitution; Chapter 1: Pharmacology of Botulinum Neurotoxins; Normal Neurotransmitter Release; BoNTs Synthesis and Structure; BoNT Binding/Blocking; BoNT Potency and Dosing; Clinical Implications of BoNT Pharmacology; Antigenicity, Antibody Formation, and Nonresponsiveness to BoNT; Safety; Central Effects of BoNTs; Summary; Chapter 2: Comparison of Botulinum Neurotoxin Products; BoNT Approvals
BoNT Products: Antigenicity, Dilution, and DiffusionBoNT Products: Potency and Dose; Converting Units/Dose Among BoNT Products; Summary; Chapter 3: Neurotoxin Storage, Reconstitution, Handling, and Dilution; Serotype B BoNT; Serotype A BoNTs; OnabotulinumtoxinA (Botox®) Reconstitution and Handling; AbobotulinumtoxinA (Dysport®) Reconstitution and Handling; IncobotulinumtoxinA (Xeomin®) Reconstitution and Handling; RimabotulinumtoxinB (Myobloc® in the United States, NeuroBloc® Outside the United States) Reconstitution and Handling; Injection Supplies; Needle Selection Chapter 4: Guidance Techniques for Botulinum Neurotoxin InjectionsAnatomic Reference Guides, Surface Anatomy, and Palpation Guidance; EMG Guidance; Electrical Stimulation Guidance; B-Mode Ultrasound; Combinations of Techniques; Other Guidance Techniques for BoNT Injections; Summary; Chapter 5: Phenol Nerve Blocks; Why Consider Phenol Neurolysis?; Phenol Mechanism of Action; Muscle Hypertonia; Pattern of Involvement; Injection Technique and Dosing; Musculocutaneous Nerve; Obturator Nerve; Tibial Motor Nerves; Summary; Section Two: Clinical Applications of Botulinum Neurotoxins Part I: Botulinum Neurotoxins for the Treatment of Muscle Overactivity Associated with Focal Dystonia Syndromes and Upper Motor Neuron SyndromesCraniofacial Dystonia; Chapter 6: Benign Essential Blepharospasm; Chapter 7: Botulinum Neurotoxin Therapy for Hemifacial Spasm; Chapter 8: Botulinum Neurotoxin Injections for Oromandibular Dystonias; Illustrations for Craniofacial Dystonia; Cervical Dystonia; Chapter 9: Botulinum Neurotoxin Injections for Cervical Dystonia; Illustrations for Cervical Dystonia; Upper Limb, Lower Limb, and Trunk Dystonia Chapter 10: Botulinum Neurotoxin for the Treatment of Idiopathic Primary Focal Limb DystoniaChapter 11: Botulinum Neurotoxin for Treatment of Muscle Overactivity Associated with Upper Motor Neuron Syndromes; Chapter 12: Botulinum Neurotoxin for the Treatment of Trunk Dystonia/Camptocormia; Chapter 13: Botulinum Neurotoxin Injections for the Treatment of Tremor; Illustrations for Upper Limb, Lower Limb, and Trunk Dystonia; Part II: Botulinum Neurotoxins for Neurosecretory Disorders; Chapter 14: Botulinum Neurotoxin Therapy for Problematic Sialorrhea; Condition Chapter 15: Botulinum Neurotoxin Therapy for Hyperhidrosis |
| Record Nr. | UNINA-9910788065803321 |
| New York, New York : , : Demos Medical, , 2015 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Botulinum neurotoxin injection manual / / editors, Katharine E. Alter, Nicole A. Wilson
| Botulinum neurotoxin injection manual / / editors, Katharine E. Alter, Nicole A. Wilson |
| Pubbl/distr/stampa | New York, New York : , : Demos Medical, , 2015 |
| Descrizione fisica | 1 online resource (369 p.) |
| Disciplina | 615.7/78 |
| Soggetto topico |
Botulinum toxin - Therapeutic use
Injections Nervous system - Diseases - Treatment |
| ISBN | 1-61705-209-4 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Cover; Title; Copyright; Contents; Contributors; Preface; Share Botulinum Neurotoxin Injection Manual; Section One: Botulinum Neurotoxin: Basic Science and Reconstitution; Chapter 1: Pharmacology of Botulinum Neurotoxins; Normal Neurotransmitter Release; BoNTs Synthesis and Structure; BoNT Binding/Blocking; BoNT Potency and Dosing; Clinical Implications of BoNT Pharmacology; Antigenicity, Antibody Formation, and Nonresponsiveness to BoNT; Safety; Central Effects of BoNTs; Summary; Chapter 2: Comparison of Botulinum Neurotoxin Products; BoNT Approvals
BoNT Products: Antigenicity, Dilution, and DiffusionBoNT Products: Potency and Dose; Converting Units/Dose Among BoNT Products; Summary; Chapter 3: Neurotoxin Storage, Reconstitution, Handling, and Dilution; Serotype B BoNT; Serotype A BoNTs; OnabotulinumtoxinA (Botox®) Reconstitution and Handling; AbobotulinumtoxinA (Dysport®) Reconstitution and Handling; IncobotulinumtoxinA (Xeomin®) Reconstitution and Handling; RimabotulinumtoxinB (Myobloc® in the United States, NeuroBloc® Outside the United States) Reconstitution and Handling; Injection Supplies; Needle Selection Chapter 4: Guidance Techniques for Botulinum Neurotoxin InjectionsAnatomic Reference Guides, Surface Anatomy, and Palpation Guidance; EMG Guidance; Electrical Stimulation Guidance; B-Mode Ultrasound; Combinations of Techniques; Other Guidance Techniques for BoNT Injections; Summary; Chapter 5: Phenol Nerve Blocks; Why Consider Phenol Neurolysis?; Phenol Mechanism of Action; Muscle Hypertonia; Pattern of Involvement; Injection Technique and Dosing; Musculocutaneous Nerve; Obturator Nerve; Tibial Motor Nerves; Summary; Section Two: Clinical Applications of Botulinum Neurotoxins Part I: Botulinum Neurotoxins for the Treatment of Muscle Overactivity Associated with Focal Dystonia Syndromes and Upper Motor Neuron SyndromesCraniofacial Dystonia; Chapter 6: Benign Essential Blepharospasm; Chapter 7: Botulinum Neurotoxin Therapy for Hemifacial Spasm; Chapter 8: Botulinum Neurotoxin Injections for Oromandibular Dystonias; Illustrations for Craniofacial Dystonia; Cervical Dystonia; Chapter 9: Botulinum Neurotoxin Injections for Cervical Dystonia; Illustrations for Cervical Dystonia; Upper Limb, Lower Limb, and Trunk Dystonia Chapter 10: Botulinum Neurotoxin for the Treatment of Idiopathic Primary Focal Limb DystoniaChapter 11: Botulinum Neurotoxin for Treatment of Muscle Overactivity Associated with Upper Motor Neuron Syndromes; Chapter 12: Botulinum Neurotoxin for the Treatment of Trunk Dystonia/Camptocormia; Chapter 13: Botulinum Neurotoxin Injections for the Treatment of Tremor; Illustrations for Upper Limb, Lower Limb, and Trunk Dystonia; Part II: Botulinum Neurotoxins for Neurosecretory Disorders; Chapter 14: Botulinum Neurotoxin Therapy for Problematic Sialorrhea; Condition Chapter 15: Botulinum Neurotoxin Therapy for Hyperhidrosis |
| Record Nr. | UNINA-9910812965203321 |
| New York, New York : , : Demos Medical, , 2015 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Spasticity : diagnosis and management / / editor, Allison Brashear ; associate editor, Elie Elovic ; contributors, Katharine E. Alter, MD [and forty-seven others]
| Spasticity : diagnosis and management / / editor, Allison Brashear ; associate editor, Elie Elovic ; contributors, Katharine E. Alter, MD [and forty-seven others] |
| Edizione | [2nd ed.] |
| Pubbl/distr/stampa | New York, New York : , : Demos Medical, , 2016 |
| Descrizione fisica | 1 online resource (513 p.) |
| Disciplina | 616.8/56 |
| Soggetto topico |
Spasticity - Diagnosis
Spasticity - Treatment |
| Soggetto genere / forma | Electronic books. |
| ISBN | 1-61705-242-6 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Cover; Title; Copyright; Contents; Contributors; Preface; Acknowledgments; Share Spasticity: Diagnosis and Management, Second Edition; Part I: General Overview; Chapter 1: Why Is Spasticity Treatment Important?; Chapter 2: Epidemiology of Spasticity in the Adult and Child; Stroke; Spinal Cord Injury; Multiple Sclerosis; Cerebral Palsy; Conclusion; References; Chapter 3: Spasticity and Other Signs of the Upper Motor Neuron Syndrome; Negative Signs; Stretch-Sensitive Positive Signs; Positive Signs That are Not Stretch Sensitive; Maladaptive Consequences of the UMNS; Conclusions; References
Chapter 4: Ancillary Findings Associated With SpasticitySensory Disturbances; Voice, Speech, and Swallowing; Bowel and Bladder; Sleep; Psychosocial Issues; Case Study; Conclusions; References; Part II: Assessment Tools; Chapter 5: Measurement Tools and Treatment Outcomes in Patients With Spasticity; Spasticity Outcome Measures-What is a Useful Outcome Measure?; An Organized Approach to Spasticity Outcomes; Physiological Measures; QOL Measures; Choosing an Outcome Measure to Assess Intervention Effectiveness; Types of Assessment Methods and Tools; Measures of Voluntary Activity Functional MeasuresQOL Measures; Conclusions; References; Chapter 6: Techniques and Scales for Measuring Spastic Paresis; Definition of Spasticity; Measure of Spasticity: The Ashworth and Tardieu Scales; Definitions of Stretch-Sensitive Paresis and Spastic Cocontraction; Assessment of the Range of Active Movement and of Its Decrement After Repeated Maximal Efforts, as Net Results of Paresis and Spastic Cocontraction; Conclusion; References; Chapter 7: Assessment of Spasticity in the Upper Extremity; Identifying Goals in Upper Extremity Assessment Anatomic Considerations in Assessing the Upper ExtremityAssessment of the Shoulder; Assessment of the Elbow; Assessment of the Wrist; Assessment of the Fingers; Functional Considerations in Assessment of the Upper Extremity; Development of the Treatment Plan to Assess Upper Extremity Spasticity; Follow-Up Assessments of Upper Extremity Spasticity; Summary; References; Chapter 8: Assessment of Lower Limb Spasticity and Other Consequences of the Upper Motor Neuron Syndrome; Clinical Assessment of Spasticity; Functional Assessment of Gait to Evaluate Lower Limb Dysfunction; References Chapter 9: Setting Realistic and Meaningful Goals for TreatmentChoosing Meaningful and Realistic Treatment Goals; Determining Treatment Goals; Goal Attainment Scale; Conclusion: Synthesis of Information and Choosing Treatment Goals; Case Discussions; References; Part III: Treatment of Spasticity; Chapter 10: Chemoneurolysis With Phenol and Alcohol: A "Dying Art" That Merits Revival; Chemical Neurolysis; Phenol; Alcohol; Comparison of Phenol Neurolysis and BoNT; Pediatric Considerations; Suggested Approaches for Specific Upper Motor Neuron Disorders; Conclusion; References Chapter 11: Botulinum Toxin in the Treatment of Lower Limb Spasticity |
| Record Nr. | UNINA-9910460752803321 |
| New York, New York : , : Demos Medical, , 2016 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Spasticity : diagnosis and management / / editor, Allison Brashear ; associate editor, Elie Elovic ; contributors, Katharine E. Alter, MD [and forty-seven others]
| Spasticity : diagnosis and management / / editor, Allison Brashear ; associate editor, Elie Elovic ; contributors, Katharine E. Alter, MD [and forty-seven others] |
| Edizione | [2nd ed.] |
| Pubbl/distr/stampa | New York, New York : , : Demos Medical, , 2016 |
| Descrizione fisica | 1 online resource (513 p.) |
| Disciplina | 616.8/56 |
| Soggetto topico |
Spasticity - Diagnosis
Spasticity - Treatment |
| ISBN | 1-61705-242-6 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Cover; Title; Copyright; Contents; Contributors; Preface; Acknowledgments; Share Spasticity: Diagnosis and Management, Second Edition; Part I: General Overview; Chapter 1: Why Is Spasticity Treatment Important?; Chapter 2: Epidemiology of Spasticity in the Adult and Child; Stroke; Spinal Cord Injury; Multiple Sclerosis; Cerebral Palsy; Conclusion; References; Chapter 3: Spasticity and Other Signs of the Upper Motor Neuron Syndrome; Negative Signs; Stretch-Sensitive Positive Signs; Positive Signs That are Not Stretch Sensitive; Maladaptive Consequences of the UMNS; Conclusions; References
Chapter 4: Ancillary Findings Associated With SpasticitySensory Disturbances; Voice, Speech, and Swallowing; Bowel and Bladder; Sleep; Psychosocial Issues; Case Study; Conclusions; References; Part II: Assessment Tools; Chapter 5: Measurement Tools and Treatment Outcomes in Patients With Spasticity; Spasticity Outcome Measures-What is a Useful Outcome Measure?; An Organized Approach to Spasticity Outcomes; Physiological Measures; QOL Measures; Choosing an Outcome Measure to Assess Intervention Effectiveness; Types of Assessment Methods and Tools; Measures of Voluntary Activity Functional MeasuresQOL Measures; Conclusions; References; Chapter 6: Techniques and Scales for Measuring Spastic Paresis; Definition of Spasticity; Measure of Spasticity: The Ashworth and Tardieu Scales; Definitions of Stretch-Sensitive Paresis and Spastic Cocontraction; Assessment of the Range of Active Movement and of Its Decrement After Repeated Maximal Efforts, as Net Results of Paresis and Spastic Cocontraction; Conclusion; References; Chapter 7: Assessment of Spasticity in the Upper Extremity; Identifying Goals in Upper Extremity Assessment Anatomic Considerations in Assessing the Upper ExtremityAssessment of the Shoulder; Assessment of the Elbow; Assessment of the Wrist; Assessment of the Fingers; Functional Considerations in Assessment of the Upper Extremity; Development of the Treatment Plan to Assess Upper Extremity Spasticity; Follow-Up Assessments of Upper Extremity Spasticity; Summary; References; Chapter 8: Assessment of Lower Limb Spasticity and Other Consequences of the Upper Motor Neuron Syndrome; Clinical Assessment of Spasticity; Functional Assessment of Gait to Evaluate Lower Limb Dysfunction; References Chapter 9: Setting Realistic and Meaningful Goals for TreatmentChoosing Meaningful and Realistic Treatment Goals; Determining Treatment Goals; Goal Attainment Scale; Conclusion: Synthesis of Information and Choosing Treatment Goals; Case Discussions; References; Part III: Treatment of Spasticity; Chapter 10: Chemoneurolysis With Phenol and Alcohol: A "Dying Art" That Merits Revival; Chemical Neurolysis; Phenol; Alcohol; Comparison of Phenol Neurolysis and BoNT; Pediatric Considerations; Suggested Approaches for Specific Upper Motor Neuron Disorders; Conclusion; References Chapter 11: Botulinum Toxin in the Treatment of Lower Limb Spasticity |
| Record Nr. | UNINA-9910797806603321 |
| New York, New York : , : Demos Medical, , 2016 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Spasticity : diagnosis and management / / editor, Allison Brashear ; associate editor, Elie Elovic ; contributors, Katharine E. Alter, MD [and forty-seven others]
| Spasticity : diagnosis and management / / editor, Allison Brashear ; associate editor, Elie Elovic ; contributors, Katharine E. Alter, MD [and forty-seven others] |
| Edizione | [2nd ed.] |
| Pubbl/distr/stampa | New York, New York : , : Demos Medical, , 2016 |
| Descrizione fisica | 1 online resource (513 p.) |
| Disciplina | 616.8/56 |
| Soggetto topico |
Spasticity - Diagnosis
Spasticity - Treatment |
| ISBN | 1-61705-242-6 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Cover; Title; Copyright; Contents; Contributors; Preface; Acknowledgments; Share Spasticity: Diagnosis and Management, Second Edition; Part I: General Overview; Chapter 1: Why Is Spasticity Treatment Important?; Chapter 2: Epidemiology of Spasticity in the Adult and Child; Stroke; Spinal Cord Injury; Multiple Sclerosis; Cerebral Palsy; Conclusion; References; Chapter 3: Spasticity and Other Signs of the Upper Motor Neuron Syndrome; Negative Signs; Stretch-Sensitive Positive Signs; Positive Signs That are Not Stretch Sensitive; Maladaptive Consequences of the UMNS; Conclusions; References
Chapter 4: Ancillary Findings Associated With SpasticitySensory Disturbances; Voice, Speech, and Swallowing; Bowel and Bladder; Sleep; Psychosocial Issues; Case Study; Conclusions; References; Part II: Assessment Tools; Chapter 5: Measurement Tools and Treatment Outcomes in Patients With Spasticity; Spasticity Outcome Measures-What is a Useful Outcome Measure?; An Organized Approach to Spasticity Outcomes; Physiological Measures; QOL Measures; Choosing an Outcome Measure to Assess Intervention Effectiveness; Types of Assessment Methods and Tools; Measures of Voluntary Activity Functional MeasuresQOL Measures; Conclusions; References; Chapter 6: Techniques and Scales for Measuring Spastic Paresis; Definition of Spasticity; Measure of Spasticity: The Ashworth and Tardieu Scales; Definitions of Stretch-Sensitive Paresis and Spastic Cocontraction; Assessment of the Range of Active Movement and of Its Decrement After Repeated Maximal Efforts, as Net Results of Paresis and Spastic Cocontraction; Conclusion; References; Chapter 7: Assessment of Spasticity in the Upper Extremity; Identifying Goals in Upper Extremity Assessment Anatomic Considerations in Assessing the Upper ExtremityAssessment of the Shoulder; Assessment of the Elbow; Assessment of the Wrist; Assessment of the Fingers; Functional Considerations in Assessment of the Upper Extremity; Development of the Treatment Plan to Assess Upper Extremity Spasticity; Follow-Up Assessments of Upper Extremity Spasticity; Summary; References; Chapter 8: Assessment of Lower Limb Spasticity and Other Consequences of the Upper Motor Neuron Syndrome; Clinical Assessment of Spasticity; Functional Assessment of Gait to Evaluate Lower Limb Dysfunction; References Chapter 9: Setting Realistic and Meaningful Goals for TreatmentChoosing Meaningful and Realistic Treatment Goals; Determining Treatment Goals; Goal Attainment Scale; Conclusion: Synthesis of Information and Choosing Treatment Goals; Case Discussions; References; Part III: Treatment of Spasticity; Chapter 10: Chemoneurolysis With Phenol and Alcohol: A "Dying Art" That Merits Revival; Chemical Neurolysis; Phenol; Alcohol; Comparison of Phenol Neurolysis and BoNT; Pediatric Considerations; Suggested Approaches for Specific Upper Motor Neuron Disorders; Conclusion; References Chapter 11: Botulinum Toxin in the Treatment of Lower Limb Spasticity |
| Record Nr. | UNINA-9910807446603321 |
| New York, New York : , : Demos Medical, , 2016 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||